©The Author(s) 2025.
World J Nephrol. Jun 25, 2025; 14(2): 102713
Published online Jun 25, 2025. doi: 10.5527/wjn.v14.i2.102713
Published online Jun 25, 2025. doi: 10.5527/wjn.v14.i2.102713
Table 2 Histopathological characteristics in patients with proliferative lupus nephritis, n (%)
| n = 207 | |
| Total glomeruli ± SD | 19.43 ± 7.39 |
| Globally sclerosed ± SD | 1.31 ± 2.60 |
| Presence of crescents | 74 (35.7) |
| Mesangial/endocapillary proliferation | |
| Focal | 49 (23.67) |
| Diffuse | 158 (76.32) |
| Interstitial fibrosis/tubular atrophy | |
| None | 43 (20.7) |
| Mild | 111 (53.62) |
| Moderate | 38 (18.35) |
| Severe | 3 (1.44) |
| IgA | 133 (64.3) |
| IgG | 164 (79.2) |
| IgM | 160 (77.3) |
| C3 | 180 (87) |
| C1q | 160 (77.3) |
- Citation: Ahmed S, Elahi T, Mubarak M, Ahmed E. Clinicopathological characteristics and long-term outcomes of adult patients with proliferative lupus nephritis. World J Nephrol 2025; 14(2): 102713
- URL: https://www.wjgnet.com/2220-6124/full/v14/i2/102713.htm
- DOI: https://dx.doi.org/10.5527/wjn.v14.i2.102713